JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1.
about
Expression of PPARdelta in multistage carcinogenesis of the colorectum: implications of malignant cancer morphologyThe significance of PITX2 overexpression in human colorectal cancerProstaglandin E2 induces contraction of liver myofibroblasts by activating EP3 and FP prostanoid receptorsHepatotoxicity induced by coxibs: how concerned should we be?Increased expression of cyclooxygenase-2 is associated with the progression to cirrhosis.Gut-liver axis improves with meloxicam treatment after cirrhotic liver resectionCyclooxygenase-2 is a target of microRNA-16 in human hepatoma cellsGadoxetic acid-enhanced MRI and sonoelastography: non-invasive assessments of chemoprevention of liver fibrosis in thioacetamide-induced rats with Sho-Saiko-To.Transgenic mice expressing cyclooxygenase-2 in hepatocytes reveal a minor contribution of this enzyme to chemical hepatocarcinogenesisTumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma.Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer.Evaluation of epigenetic modulation of cyclooxygenase-2 as a prognostic marker for hepatocellular carcinomaThe antifibrotic and fibrolytic properties of date fruit extract via modulation of genotoxicity, tissue-inhibitor of metalloproteinases and nuclear factor- kappa B pathway in a rat model of hepatotoxicityQuantitative evaluation of vimentin expression in tumour stroma of colorectal cancerFull-length LGR5-positive cells have chemoresistant characteristics in colorectal cancer.miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1.Cyclooxygenase-2 Inhibitor Reduces Hepatic Stiffness in Pediatric Chronic Liver Disease Patients Following Kasai Portoenterostomy.Cyclooxygenase-2 mediates dialysate-induced alterations of the peritoneal membraneCelecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats.The Clinical Impact of Transcatheter Arterial Chemoembolization (TACE)-Induced c-Met Upregulation on TACE Refractoriness in Hepatocellular Carcinoma.Regulation of MicroRNA 183 by Cyclooxygenase 2 in Liver Is DEAD-Box Helicase p68 (DDX5) Dependent: Role in Insulin Signaling.Cyclooxygenase-2 single-nucleotide polymorphisms and hepatocellular carcinoma in Egypt.C4.4A is associated with tumor budding and epithelial-mesenchymal transition of colorectal cancer.Cyclo-oxygenase 2 expression impairs serum-withdrawal-induced apoptosis in liver cells.Effects of acetyl salycilic acid and ibuprofen in chronic liver damage induced by CCl4.Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase.Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy.Celecoxib, a selective cyclooxygenase-2 inhibitor, lowers plasma cholesterol and attenuates hepatic lipid peroxidation during carbon-tetrachloride-associated hepatotoxicity in rats.Electroporative alpha-MSH gene transfer attenuates thioacetamide-induced murine hepatic fibrosis by MMP and TIMP modulation.Effect of celecoxib on experimental liver fibrosis in rat.Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis.Adipose-Derived Stem Cells Ameliorate Experimental Murine Colitis via TSP-1-Dependent Activation of Latent TGF-β.Inspection of Perirectal Lymph Nodes by One-Step Nucleic Acid Amplification Predicts Lateral Lymph Node Metastasis in Advanced Rectal Cancer.Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury.Magnesium chenoursodeoxycholic acid ameliorates carbon tetrachloride-induced liver fibrosis in rats.Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome.
P2860
Q24652863-8CB1B1C2-BF01-4E54-A678-772CCE8ECE44Q28235167-7F0F4794-7466-49CB-B1B9-AD2CA7D81418Q28569384-E75B07DF-18AE-41A7-9CB5-08FCD0FA29E7Q30244369-29972DB1-94E9-4682-AC29-E4714B6F0922Q34384999-7D380D34-92AB-4C31-85EC-619B201995F4Q34405116-E09F2724-E492-42D8-8A71-1AA07086B864Q34506147-E8268C2A-AFB6-4A8D-8DBF-D59FBC22C9BCQ34663436-86A3E18E-8826-4A51-865E-95D1C39A7167Q34756135-EB197DDB-E76E-4BFF-8841-11F59B0E4088Q35010488-071429B1-6BC4-4C15-BBB1-4DB13B508990Q35161368-EDA952CE-9CAB-4974-99D4-A0A4FE234B9CQ36143166-66C46404-65D1-4926-A679-C009CA8EFE35Q36173424-BFBB42C4-5CFF-4CB7-AE8A-4175E01B2CF6Q36610121-34D53A2B-49F9-4D2E-85BB-655A5A0DCA71Q36964320-6B61E120-4D96-406E-B4E2-BF5A341CB7E3Q37040632-7853B7C8-D33A-4926-82B7-8B2B44002D8EQ37110171-A69BF897-02E1-4FA0-BD47-94243F185390Q37123283-A5AB2C51-1BE4-4A39-A532-EC0757542EC9Q37262768-A0204C3D-B148-4560-A8BF-4EAF1E769D01Q38806970-C0419FFC-264E-4943-8C8A-33B1FB34CD6FQ38876354-6A4E6DB6-28AF-4966-9EF2-711C14BD462AQ39258273-1CB0E1BE-30A4-4DFD-8978-B01D939FAE72Q39382631-B3820251-E953-462A-B049-454EF5095062Q40262676-4FB757EC-3AFD-40DB-8E5D-56E4D9B9AF12Q40332441-97521E5B-873A-41B9-B2EB-871C215C6E22Q40524016-6EF869BC-4327-47D1-8BD2-C6C6FAF19C29Q42591676-76BF079A-93EC-4A84-9009-143799DE7F5FQ44710269-B21E6143-3604-4F94-A344-4612FD994DD2Q45856457-4326CB90-BFBB-4AF1-896B-12FF76025FD5Q46899606-1777F833-F2B7-4E03-994F-1A062F768185Q47272307-DE09D396-0AAC-4460-BB30-B51FA3DADC4FQ48244480-9952E610-9EC6-481B-AD9F-4C8594FCAB39Q50027790-778399D7-49DB-40D9-BFAA-B01076C7D978Q53547058-4BAAA8B0-6887-4DB1-BD24-BD7784A382A4Q54541850-377E6B88-9DB4-4535-9EE2-F8663C4EA6E1Q54638060-7B2864A9-0265-42D4-A309-EAB355023676
P2860
JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
JTE-522, a cyclooxygenase-2 in ...... experimental liver fibrosis1.
@ast
JTE-522, a cyclooxygenase-2 in ...... experimental liver fibrosis1.
@en
JTE-522, a cyclooxygenase-2 in ...... experimental liver fibrosis1.
@nl
type
label
JTE-522, a cyclooxygenase-2 in ...... experimental liver fibrosis1.
@ast
JTE-522, a cyclooxygenase-2 in ...... experimental liver fibrosis1.
@en
JTE-522, a cyclooxygenase-2 in ...... experimental liver fibrosis1.
@nl
prefLabel
JTE-522, a cyclooxygenase-2 in ...... experimental liver fibrosis1.
@ast
JTE-522, a cyclooxygenase-2 in ...... experimental liver fibrosis1.
@en
JTE-522, a cyclooxygenase-2 in ...... experimental liver fibrosis1.
@nl
P2093
P1433
P1476
JTE-522, a cyclooxygenase-2 in ...... experimental liver fibrosis1.
@en
P2093
Bazarragchaa Damdinsuren
Hiroaki Nagano
Hirofumi Yamamoto
Jin Chang-De
Keizo Dono
Ken-Ichi Wakasa
Koji Umeshita
Masato Sakon
Mitsugu Sekimoto
Morito Monden
P304
P356
10.1016/S0016-5085(03)00904-1
P407
P577
2003-08-01T00:00:00Z